WIPO logo
Celular | Deutsch | English | Español | Français | 日本語 | 한국어 | Русский | 中文 | العربية |
PATENTSCOPE

Pesquisa nas coleções internacionais e nacionais de patentes
World Intellectual Property Organization
Pesquisa
 
Navegação
 
Traduzir
 
Opções
 
Notícias
 
Conectar-se
 
Ajuda
 
Tradução automática
1. (WO2001010406) FACILITATING THE PRESERVATION OF SIGHT BY INCREASING OPTIC NERVE, CHOROIDAL AND RETINAL BLOOD FLOW
Dados bibliográficos mais recentes no arquivo da Secretaria Internacional   

№ de pub.:    WO/2001/010406    № do pedido internacional:    PCT/US2000/021929
Data de publicação: 15.02.2001 Data de depósito internacional: 10.08.2000
Pedido de exame (capítulo 2) depositado:    07.03.2001    
CIP:
A61K 31/00 (2006.01), A61K 31/21 (2006.01), A61K 31/5025 (2006.01), A61K 31/519 (2006.01), A61K 33/00 (2006.01)
Requerentes: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM [US/US]; 201 West 7th St., Austin, TX 78701 (US).
SPONSEL, William, E. [US/US]; (US) (For US Only)
Inventores: SPONSEL, William, E.; (US)
Mandatário: SCHULTZ, Teresa, J.; Fulbright & Jaworski, L.L.P., Suite 2400, 600 Congress Avenue, Austin, TX 78701 (US).
GLAWE, DELFS, MOLL; Rothenbaumchaussee 58, 20148 Hamburg (DE)
Dados da prioridade:
60/148,150 10.08.1999 US
Título (EN) FACILITATING THE PRESERVATION OF SIGHT BY INCREASING OPTIC NERVE, CHOROIDAL AND RETINAL BLOOD FLOW
(FR) PROCEDE PERMETTANT D'AUGMENTER L'ECOULEMENT SANGUIN DANS LE NERF OPTIQUE, LA RETINE ET LA CHOROIDE AFIN DE FACILITER LA PRESERVATION DE LA VUE
Resumo: front page image
(EN)A method for improving visual function and maximizing the health of the optic nerve and retina by increasing blood flow velocity therein through the application of an effective amount of a formulation of an agent that increases levels of cyclic-GMP, increases levels of nitric oxide or inhibits phosphodiesterase.
(FR)L'invention concerne un procédé permettant d'améliorer la fonction visuelle et d'augmenter le plus possible la santé du nerf optique et de la rétine par augmentation de la vitesse de l'écoulement sanguin. Ce procédé consiste à appliquer une quantité efficace d'une préparation d'un agent augmentant les niveaux de GMP cyclique et les niveaux d'oxyde nitrique ou inhibant la phosphodiestérase.
Estados designados: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Língua de publicação: English (EN)
Língua de depósito: English (EN)